Sunday, August 28, 2011

Thirteen Fitzsimons Companies Selected to Present at Regional Life Science Conference

Companies from the Colorado Science + Technology Park at Fitzsimons will comprise about half of all presenters at this year’s Rocky Mountain Life Science Investor and Partnering Conference. Located at the Brown Palace Hotel in Downtown Denver, the event will feature 30 presenting companies. The conference is organized by the Colorado BioScience Association as the Rocky Mountain region’s premier investor and partner conference. Link to the news release pdf

Friday, August 26, 2011

CCS' Suellen Scott and Rodrigo help 9News' Patti Dennis celebrate her Outstanding Women in Business award

The Cat Care Society's own Suellen Scott and resident kitty Rodrigo helped 9News' Patti Dennis celebrate her 'Outstanding Women in Business' award presented this week by the Denver Business Journal. Patti Dennis started PetLine 9 (among many more contributions).

Suellen and Rodrigo were at the 9News studios for a PetLine 9 interview when the Denver Business Journal photographer Kathleen Levine was shooting Patti's award photos.

Congratulations, Patti!

Link to the article

Thursday, August 25, 2011

MassDevice: 'Colorado Sen. to FDA: Regulatory science isn't enough'

Quoting from the posting:

"The FDA's newly minted plan to revamp its scientific methods isn't enough to ensure that the watchdog agency is doing its part in driving the global economy, according to junior Senator Michael Bennet (CO-D).

'I applaud the FDA's efforts to advance regulatory science through the recent release of the Agency's - Strategic Plan for Regulatory Science -but believe there is much more to be done,' Bennet wrote in a recent letter to FDA head Dr. Margaret Hamburg."

Further, on Monday (Aug 22) Senator Bennet brought FDA Commissioner Hamburg to Colorado, with two administration colleagues for a CEO Roundtable assembled by the Colorado BioScience Association at the Anschutz Medical Campus.




Tuesday, August 23, 2011

CEO Roundtable: Senator Michael Bennet, FDA Commissioner Margaret Hamburg at Anschutz Medical Campus Yesterday

The Colorado BioScience Association (CBSA) worked with Senator Michael Bennet's office in assembling a group of more than 35 bioscience industry CEOs from its membership to dialogue with the Senator and Margaret Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration (FDA). Dr. Jeffrey Shuren, Director, Center for Devices and Radiological Health, and Dr. Vicki Seyfert-Margolis, Senior Science Advisor to the FDA’s Chief Scientist, accompanied Commissioner Hamburg here.

The announcement is made by Holli Riebel (formerly Baumunk), CBSA President & CEO, who says "Senator Bennet invited Commissioner Hamburg and her colleagues to Colorado for the CEO Roundtable. The session is a positive next step to work CBSA has already contributed to Senator Bennet's Coloradoans For An Innovation Economy (CFAIE), and speaks strongly to the work the Senator is doing on our industry's behalf. We appreciate the opportunity to host Commissioner Hamburg in our state for the first time and share our industry's specific and unique needs for bringing innovative drugs and devices to market under current, often constraining, market conditions."

According to Lilly Marks, VP for Health Affairs and Executive Vice Chancellor, Anschutz Medical Campus, the Roundtable session took place on the Anschutz Medical Campus in Aurora where the FDA delegation also toured research and clinical trial facilities before departing the city.

Link to the Business Wire release

Friday, August 19, 2011

NCBR: 'Fort Collins companies to present at Denver science conference'

Quoting from the August 17th posting:

"DENVER - Three Fort Collins companies will present at the 2011 Rocky Mountain Life Science Investor and Partnering Conference, to be held at the Brown Palace Hotel, 321 17th St. in Denver Sept. 21 and 22. KromaTiD Inc., bioscience company focused on the creation of new products for chromosome analysis; Inviragen Inc., a vaccine development specialist; and VetDC Inc., which focuses on reverse-engineering human medicine to help treat animals, were selected to appear at the conference...The conference is presented by the Colorado Bioscience Association, and is expected to be attended by more than 50 national investment firms."

Link to ncbr.com

Tuesday, August 16, 2011

Lakewood Pet Examiner: "Cat Care Society gearing up for thrift store remodel with huge sale"

Quoting from Carrie Dow's recent posting:

"Cajun's Closet, a thrift store that supports the Cat Care Society in Lakewood, is preparing to close it doors. In two weeks it will re-open as the new and improved "The Closet" at the Cat Care Society. That's means the community can get in on some awesome deals as the store has a sale to clear out the old and bring in even more near new.

On Saturday, August 20, from 9 a.m. to 5 p.m. the thrift store that received the 2009 "Best of Lakewood" Award is having a "Renovation Sale." Shoppers will get 75% off most merchandise. They are also having a "Make an Offer" special on antiques and there is a Fill-a-Bag Clothing Extravaganza.

Don't forget to "shop" for a new kitty too! This month only all cats one year or older are $30, a savings of $60."

Link to the post, with details on how to volunteer

‎9News Denver: Another poignant reminder that we shouldn't let our cats roam outside

Quoting from the 9News website:

"LAKEWOOD - Neighbors say cats are disappearing almost daily in the area near the Denver Federal Center and nobody can explain it. They emailed 9NEWS asking us to find answers and we checked with Colorado Parks and Wildlife and Lakewood Animal Control.

Posters for missing cats have been appearing on telephone poles all over the neighborhood near South Taft Street and West Dakota Drive in Lakewood."

Link to the full article and video

Friday, August 12, 2011

NMBW: 'Two New Mexico startups to present at investor conference'

Quoting from yesterday's posting:

"Two local startups, Avisa Pharma Inc. and Azano Pharmaceuticals, were among 30 companies selected to present at the Rocky Mountain Life Science Investor & Partnering Conference in Denver Sept. 21-22.

The two companies are developing and marketing new technologies licensed from the University of New Mexico to help cystic fibrosis and lupus patients."

Link to New Mexico Business Weekly

Wednesday, August 10, 2011

Daily Camera: "11 Boulder-area companies presenting at bioscience conference"

Quoting from the article by Alicia Wallace:

"Eleven companies from Boulder and Broomfield counties will present at the upcoming Rocky Mountain Life Science Investor and Partnering Conference in Denver, officials for the Colorado BioScience Association announced Tuesday.

The local firms will be among 30 companies to make presentations to industry investors and executives at the event scheduled for Sept. 21 and 22 at the Brown Palace Hotel, 321 17th St., in Denver. The companies and the attendees hail from Colorado, Arizona, Montana, New Mexico, Oklahoma, Utah and Canada."

Link to dailycamera.com

Tuesday, August 9, 2011

Thirty Regional Companies Selected to Present at the 2011 Rocky Mountain Life Science Investor & Partnering Conference in Denver

The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO.

Link to the Business Wire

Link to the Pitch Engine Social Media Newswire

Thursday, August 4, 2011

CBSA Perspective: "Roche site in Boulder to be sold, operated as Corden Pharma"

Quoting from the Alicia Wallace report in the Boulder Daily Camera:

"The 265-person Roche Colorado site in Boulder is expected to be sold to International Chemical Investors Group, officials for both companies announced Wednesday....

'What's nice is it's such a specialized technical facility' that Roche still needs, said Holli Reibel, president and CEO of the Colorado BioScience Association. 'And (Corden) might really bring more product to the plant, which is excellent for Colorado.'

More and more, Reibel added, biotech and pharmaceutical companies have made moves to focus on their core capabilities and have opted to outsource manufacturing efforts elsewhere -- sometimes overseas. Corden Pharma, being a large contract manufacturer with an international reach, should be a welcome addition to Colorado's bioscience community, she said."

Link to the dailycamera.com coverage

Monday, August 1, 2011

CID4 Awards Funding and Management Assistance to Longmont's Flashback Technologies - "Advanced Patient Monitoring To Predict Patient Outcome"

Quoting from this morning's news release: "The Colorado Institute for Drug, Device and Diagnostic Development (CID4has selected Longmont, Colorado-based Flashback Technologies, Inc. to receive funding and management assistance. Flashback is advancing development of their proprietary learning framework for the real-time analysis of physiological data.

Hemorrhage is the number one cause of potentially preventable death on the battlefield and in civilian trauma settings. Work under development includes a device powered by software that quickly and reliably detects and estimates blood loss volume and predicts a time to cardiovascular collapse.

Discoveries at the University of Colorado, Anschutz Medical Campus, Department of Surgery, the University of Colorado, Boulder, Department of Computer Science, and the U.S. Army Institute of Surgical Research have revealed several previously unknown hemodynamic relationships leading to a patent-pending platform technology for the real-time analysis of human vital sign data. A set of algorithms, collectively termed the Cardiovascular Reserve Monitor (CRM), is under development with funding from the U.S. Army. The CRM takes as inputs non-invasive physiological sensor data that in real-time: 1) Detects the early onset of hypovolemia (blood loss) 2) Estimates blood loss volume, and 3) Predicts a patient's individual risk for cardiovascular collapse."

Link to the Pitch Engine social media release